(Q48423864)

11 February 2018

title

Autism spectrum disorder profile in neurofibromatosis type I. (English)

1 reference

11 February 2018

main subject

autism spectrum disorder

0 references

0 references

7

1 reference

11 February 2018

Jonathan Green

9

1 reference

11 February 2018

author name string

Shruti Garg

1

1 reference

11 February 2018

Ellen Plasschaert

2

1 reference

11 February 2018

Mie-Jef Descheemaeker

3

1 reference

11 February 2018

Susan Huson

4

1 reference

11 February 2018

Martine Borghgraef

5

1 reference

11 February 2018

Annick Vogels

6

1 reference

11 February 2018

Eric Legius

8

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 June 2015

1 reference

11 February 2018

Journal of Autism and Developmental Disorders

published in

1 reference

11 February 2018

volume

45

1 reference

11 February 2018

issue

6

1 reference

11 February 2018

page(s)

1649-1657

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1007/s10803-014-2321-5

exact match

0 references

cites work

Advances in autism genetics: on the threshold of a new neurobiology

1 reference

https://api.crossref.org/works/10.1007%2FS10803-014-2321-5

Lovastatin as treatment for neurocognitive deficits in neurofibromatosis type 1: phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-014-2321-5

Autism traits in the RASopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-014-2321-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-014-2321-5

Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-014-2321-5

Social skills of children with neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-014-2321-5

Behavioral signatures related to genetic disorders in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-014-2321-5

Validation of a brief quantitative measure of autistic traits: comparison of the social responsiveness scale with the autism diagnostic interview-revised.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-014-2321-5

Early grade repetition and inattention associated with neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-014-2321-5

Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-014-2321-5

Modeling cognitive dysfunction in neurofibromatosis-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-014-2321-5

Neurofibromatosis type 1 and autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-014-2321-5

Childhood psychosis and neurofibromatosis--more than a coincidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-014-2321-5

Trajectories of autism severity in children using standardized ADOS scores

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-014-2321-5

Social information processing in children and adolescents with neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-014-2321-5

The effect of apamin, a small conductance calcium activated potassium (SK) channel blocker, on a mouse model of neurofibromatosis 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-014-2321-5

Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-014-2321-5

Behaviour in children with neurofibromatosis type 1: cognition, executive function, attention, emotion, and social competence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-014-2321-5

Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-014-2321-5

Characteristics of autism spectrum disorder in Cornelia de Lange syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-014-2321-5

Delineation of behavioral phenotypes in genetic syndromes: characteristics of autism spectrum disorder, affect and hyperactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-014-2321-5

Convergence of genes and cellular pathways dysregulated in autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-014-2321-5

Prevalence of Autism Spectrum Disorder symptoms in children with neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-014-2321-5

The behavioral phenotype in fragile X: symptoms of autism in very young children with fragile X syndrome, idiopathic autism, and other developmental disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-014-2321-5

Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-014-2321-5

Rethinking the nature of genetic vulnerability to autistic spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-014-2321-5

Autistic disorder in patients with Williams-Beuren syndrome: a reconsideration of the Williams-Beuren syndrome phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-014-2321-5

Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-014-2321-5

Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-014-2321-5

Birth incidence and prevalence of tumor-prone syndromes: Estimates from a UK family genetic register service

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-014-2321-5

Genomic imprinting and the expression of affect in Angelman syndrome: what's in the smile?

21 January 2018

1 reference

12 December 2020

Social, emotional, and behavioral functioning of children with NF1

1 reference

12 December 2020

Autism and associated medical disorders in a French epidemiological survey.

1 reference

12 December 2020

Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference

1 reference

12 December 2020

Genetics of autism spectrum disorders

1 reference

12 December 2020

Neurofibromatosis in infantile autism and other types of childhood psychoses

1 reference

12 December 2020

10.1007/S10803-014-2321-5

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

25475362

1 reference

11 February 2018